Medical devices and vitamin company Ascendis has offered shareholders 80c a share to take it private, an almost 16% premium on the price when the potential delisting was first announced in September.

This will add to a spate of delistings that has seen the number of companies on the JSE drop from a high of more than 600 at the turn of the century to the current 287 — leaving fewer and fewer public businesses for pension funds to invest in.  ..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.